Xolair® adverse reactions in severe allergic asthma2
The adverse reactions observed in severe allergic asthma patients include:2
Infections and infestations | |
Uncommon | Pharyngitis |
Rare | Parasitic infection |
Blood and lymphatic system disorders | |
Not known | Idiopathic thrombocytopenia, including severe cases |
Immune system disorders | |
Rare | Anaphylactic reaction, other serious allergic conditions, anti-omalizumab antibody development |
Not known | Serum sickness, may include fever and lymphadenopathy |
Nervous system disorders | |
Common | Headache† |
Uncommon | Syncope, paraesthesia, somnolence, dizziness |
Vascular disorders | |
Uncommon | Postural hypotension, flushing |
Respiratory, thoracic and mediastinal disorders | |
Common | Allergic bronchospasm, coughing |
Rare | Laryngoedema |
Not known | Allergic granulomatous vasculitis (i.e Churg-Strauss syndrome) |
Gastrointestinal disorders | |
Common | Abdominal pain Upper†† |
Uncommon | Dyspeptic signs and symptoms, diarrhoes, nausea |
Skin and subcutaneous tissue disorders | |
Uncommon | Photosensitivy, urticaria, rash, pruritua |
Rare | Angioedema |
Not know | Alopecia |
Musculoskeketal and connective tissue disorders | |
Not known | Arthralgia, myalgia, Joint swelling |
General disorders and administration site conditions | |
Very common | Pyrexia†† |
Common | Injection site reactions such as swelling, erythema, pain, pruritus |
Uncommon | Influenza-like illness, swelling arms, weight increase, fatigue |
†Very common in children 6-<12 years of age.
††In children 6-<12 years years of age.
Frequency categories are defined as: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000)